 | | | | | | |
 | 2014 |
| |
 | 2015 |
| |
 | 2016 |
| |
  | 01 |
| |
  | 02 |
| |
  | 03 |
| |
  | 04 |
| |
  | 05 |
| |
  | 06 |
| |
  | 07 |
| |
| | 07/27/2016 | 03:00 PM | | Merck KGaA, Darmstadt, Germany, Biopharma Innovation Cup Honors Young Scientists | |  |
| | 07/19/2016 | 02:00 PM | | MilliporeSigma Starts Construction on $115 Million Multi-faceted Life Science Campus in Burlington, Massachusetts
| |  |
| | 07/18/2016 | 08:00 AM | | Merck KGaA, Darmstadt, Germany, Receives European Medicines Agency Acceptance for Review of Marketing Authorization Application for Cladribine Tablets | |  |
| | 07/18/2016 | 02:00 PM | | MilliporeSigma Relaunches Customer Collaboration Centers with New Concept and M Lab™ Name | |  |
| | 07/15/2016 | 02:30 PM | | Dietmar Eidens Appointed Chief HR Officer (CHRO) of Merck KGaA, Darmstadt, Germany | |  |
| | 07/13/2016 | 12:00 PM | | Merck KGaA, Darmstadt, Germany Awards Premio Letterario of Merck KGaA, Darmstadt, Germany in Rome | |  |
| | 07/13/2016 | 02:00 PM | | MilliporeSigma Advances Water Purification Systems with New High-Throughput Line | |  |
| | 07/12/2016 | 02:00 PM | | MilliporeSigma Expands Excipients Portfolio, Adding Polymers for Sustained Release Injectables | |  |
| | 07/08/2016 | 10:00 AM | | Merck KGaA, Darmstadt, Germany, Launches New High-Temperature Pigment Series for the Ceramics Industry | |  |
| | 07/06/2016 | 02:00 PM | | Merck KGaA, Darmstadt, Germany, and Pfizer Initiate Phase III Trial to Evaluate Avelumab as First-line Treatment for Ovarian Cancer | |  |
| | 07/01/2016 | 10:00 AM | | Johann Heinrich Merck Award of Merck KGaA, Darmstadt, Germany Goes To Kathrin Passig | |  |
| | 07/01/2016 | 02:30 PM | | Merck KGaA, Darmstadt, Germany, and University of Nairobi to Start Medical Oncology Fellowship Program | |  |
  | 08 |
| |
  | 09 |
| |
  | 10 |
| |
  | 11 |
| |
  | 12 |
| |
 | 2017 |
| |
 | 2018 |
| |